Association of SOX9 expression with sensitivity to CDK7 inhibition and overall survival in triple-negative breast cancer.

被引：0
|
作者：
Guan, Xiaoxiang
Jin, Juan
Tang, Lin
Wang, Xin
Wang, Yucai
Shu, Yongqian
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China
[4] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.1065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1065
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic role of androgen receptor expression in triple-negative breast cancer.
    Wang, Yanru
    Yang, Fang
    Wang, Yucai
    Zhong, Fengming
    Guan, Xiaoxiang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple-Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1-Regulated Cholesterol Metabolism
    Yang, Yilan
    Liao, Jiatao
    Pan, Zhe
    Meng, Jin
    Zhang, Li
    Shi, Wei
    Wang, Xiaofang
    Zhang, Xiaomeng
    Zhou, Zhirui
    Luo, Jurui
    Chen, Xingxing
    Yang, Zhaozhi
    Mei, Xin
    Ma, Jinli
    Zhang, Zhen
    Jiang, Yi-Zhou
    Shao, Zhi-Min
    Chen, Fei Xavier
    Yu, Xiaoli
    Guo, Xiaomao
    ADVANCED SCIENCE, 2024,
  • [43] Association of ALDH1A1 gene expression with survival of triple-negative breast cancer
    Liu, Yan
    Cai, Qiuyin
    Zheng, Ying
    Baglia, Michelle L.
    Su, Yinghao
    Nechuta, Sarah
    Bao, Ping-Ping
    Blot, William
    Zheng, Wei
    Shu, Xiao-Ou
    CANCER RESEARCH, 2015, 75
  • [44] Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
    Li, Xiaoxian
    Yang, Jing
    Peng, Limin
    Sahin, Aysegul A.
    Huo, Lei
    Ward, Kevin C.
    O'Regan, Ruth
    Torres, Mylin A.
    Meisel, Jane L.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (02) : 279 - 287
  • [45] MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
    Horiuchi, Dai
    Kusdra, Leonard
    Huskey, Noelle E.
    Chandriani, Sanjay
    Lenburg, Marc E.
    Gonzalez-Angulo, Ana Maria
    Creasman, Katelyn J.
    Bazarov, Alexey V.
    Smyth, James W.
    Davis, Sarah E.
    Yaswen, Paul
    Mills, Gordon B.
    Esserman, Laura J.
    Goga, Andrei
    JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (04): : 679 - 696
  • [46] Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
    Xiaoxian Li
    Jing Yang
    Limin Peng
    Aysegul A. Sahin
    Lei Huo
    Kevin C. Ward
    Ruth O’Regan
    Mylin A. Torres
    Jane L. Meisel
    Breast Cancer Research and Treatment, 2017, 161 : 279 - 287
  • [47] Response to Neoadjuvant Chemotherapy and Survival in Japanese Patients with Triple-Negative Breast Cancer.
    Ohtani, S.
    Kochi, M.
    Ito, M.
    Takada, S.
    Matsuura, H.
    Higaki, K.
    CANCER RESEARCH, 2011, 71
  • [48] Association of statin use with clinical outcomes in patients with triple-negative breast cancer.
    Nowakowska, Malgorzata
    Lei, Xiudong
    Thompson, Mikayla R.
    Shaitelman, Simona Flora
    Wehner, Mackenzie
    Woodward, Wendy A.
    Giordano, Sharon H.
    Nead, Kevin Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] Race Not a Factor in Overall Survival in Patients With Triple-Negative Breast Cancer: A Retrospective Review
    Glover-Collins, Katherine
    Starlard-Davenport, Athena
    Mahkoul, Issam
    Hutchins, Laura
    Westbrook, Kent
    Korourian, Soheila
    Enoch, Kimberly
    Preston, Michael
    Gardner, Kenneth
    Klimberg, V. Suzanne
    Henry-Tillman, Ronda
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : 52 - 52
  • [50] CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer
    Liu, Ming
    Tsang, Julia Y. S.
    Lee, Michelle
    Ni, Yun-Bi
    Chan, Siu-Ki
    Cheung, Sai-Yin
    Hu, Jintao
    Hu, Hong
    Tse, Gary M. K.
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (11) : 1007 - 1014
12345